Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.49 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5700 | 0.83 | LTA4H (0.80) | LTA4HEPHX2FFAR1CYP4F2CYP4A11 | |
| SCHEMBL22862360 | 0.82 | CA2 (0.54) | FFAR1CYP4F2CYP4A11FFAR4CA2 | |
| SCHEMBL966309 | 0.81 | MAOB (0.69) | LTA4HEPHX2APPMAOB | |
| SCHEMBL9121493 | 0.81 | FFAR1 (0.66) | LTA4HEPHX2FFAR1APPMAOB | |
| SCHEMBL9125234 | 0.81 | MAOB (0.60) | LTA4HEPHX2FFAR1CYP4F2CYP4A11 | |
| SCHEMBL6029 | 0.81 | CYP4F2 (0.71) | LTA4HEPHX2FFAR1CYP4F2CYP4A11 | |
| Alcohol SCHEMBL5852437 | 0.79 | LTA4H (0.73) | LTA4HEPHX2FFAR1CYP4F2CYP4A11 | |
| SCHEMBL18002747 | 0.77 | MAOB (0.69) | LTA4HEPHX2FFAR1FFAR4PTPN1 | |
| SCHEMBL14786201 | 0.76 | MAOB (0.71) | LTA4HEPHX2FFAR1CA2PTPN1 | |
| SCHEMBL24802691 | 0.76 | ACACB (0.51) | FFAR1FFAR4PTPN1PTPN6PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210149098-A1 | OPTICAL ELEMENT, METHOD FOR FORMING PHOTO-ALIGNMENT PATTERN, AND METHOD FOR MANUFACTURING OPTICAL ELEMENT | FUJIFILM CORPORATION (JP) | 2021-05-20 | — | — | US | disclosed |
| US-20210002556-A1 | COMPOUND, COMPOSITION, CURED OBJECT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | FUJIFILM CORPORATION (JP) | 2021-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002556-A1 | COMPOUND, COMPOSITION, CURED OBJECT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | MKI67, RB1, FLNA | LTA4H 318/4885EPHX2 1506/4885FFAR1 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.